NCT03416374 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- groups
- description
- Bortezomib + Lenalidomide + Dexamethasone, standard recommended dose according to the package insert of each drug (Treatment Period I), followed by Ixazomib (4.0 mg) on Days 1, 8 and 15, plus Lenalidomide (25 mg) on Days 1 to 21, and Dexamethasone (40 mg) on Days 1, 8, 15 and 22, of a 28-day cycle (Treatment Period II)
- id
- BG000
- title
- [VRd]; Bortezomib + Lenalidomide + Dexamethasone Therapy
- description
- Carfilzomib + Lenalidomide + Dexamethasone, standard recommended dose according to the package insert of each drug (Treatment Period I), followed by Ixazomib (4.0 mg) on Days 1, 8 and 15, plus Lenalidomide (25 mg) on Days 1 to 21, and Dexamethasone (40 mg) on Days 1, 8, 15 and 22, of a 28-day cycle (Treatment Period II)
- id
- BG001
- title
- [KRd]; Carfilzomib + Lenalidomide + Dexamethasone Therapy
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.57
- value
- 71.8
- group Id
- BG001
- spread
- 9.40
- value
- 70.5
- group Id
- BG002
- spread
- 9.21
- value
- 70.7
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 21
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 24
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG002
- value
- 0
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Race and Ethnicity were not collected from any participant.
- title
- Race and Ethnicity Not Collected
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Japan
- description
- All participants were enrolled in Japan.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.70
- value
- 153.0
- group Id
- BG001
- spread
- 8.29
- value
- 158.5
- group Id
- BG002
- spread
- 8.58
- value
- 157.8
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height
- unit Of Measure
- Centimeters (cm)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.204
- value
- 52.85
- group Id
- BG001
- spread
- 10.380
- value
- 57.87
- group Id
- BG002
- spread
- 10.081
- value
- 57.17
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 43
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- Weight
- unit Of Measure
- Kilograms (kg)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 2.619
- value
- 22.60
- group Id
- BG001
- spread
- 2.512
- value
- 22.91
- group Id
- BG002
- spread
- 2.497
- value
- 22.86
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 43
- units
- Participants
- description
- Body Mass Index = weight (kg)/\[height (m)\^2\]
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- BMI
- unit Of Measure
- Kilogram (kg)/meter (m)^2]
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.1395
- value
- 1.487
- group Id
- BG001
- spread
- 0.1760
- value
- 1.583
- group Id
- BG002
- spread
- 0.1732
- value
- 1.569
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 43
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- Body Surface Area
- unit Of Measure
- m^2
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 19
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage I
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 17
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage II
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 9
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage III
- description
- International Staging System is a staging system for cancer progression. Stages are classified by Stage I to Stage III. Stage I: Serum beta2-microglobulin \<3.5 mg/L and albumin ≥3.5 g/dL; Stage II: Neither Stage I or III, meaning that either: beta2-microglobulin level ≥3.5 and \<5.5 mg/L (with any albumin level), OR albumin \<3.5 g/dL with beta2-microglobulin \<3.5 mg/L; Stage III: Serum beta2-microglobulin ≥5.5 mg/L. Normal serum beta2-microglobulin: \<3.0 mg/L; normal albumin: 3.5-5.0 g/dL.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- International Staging System (at Initial Diagnosis)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 24
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage I
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 13
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage II
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 5
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage III
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- International Staging System (at First Treatment [Period I])
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 33
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Scale = 0
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 10
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Scale = 1
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Scale = 2
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Scale = 3
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Scale = 4
- description
- ECOG P.S.) assess participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory ( greater than \[\>\] 50 percent \[%\] of waking hours), capable of all self-care, unable to carry out any work activities; 3=capable of only limited self-care, confined to bed/chair \>50% of waking hours; 4=completely disabled, cannot carry on any self-care, totally confined to bed/chair; 5=dead.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group performance status (ECOG P.S.)
- unit Of Measure
- Participants
- population Description
- Full Analysis Set (FAS): all participants who were enrolled in Treatment Period I and who receive at least one dose of any therapy during the Treatment Period.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- groups
- description
- Bortezomib + Lenalidomide + Dexamethasone, standard recommended dose according to the package insert of each drug (Treatment Period I), followed by Ixazomib (4.0 mg) on Days 1, 8 and 15, plus Lenalidomide (25 mg) on Days 1 to 21, and Dexamethasone (40 mg) on Days 1, 8, 15 and 22, of a 28-day cycle (Treatment Period II)
- id
- BG000
- title
- [VRd]; Bortezomib + Lenalidomide + Dexamethasone Therapy
- description
- Carfilzomib + Lenalidomide + Dexamethasone, standard recommended dose according to the package insert of each drug (Treatment Period I), followed by Ixazomib (4.0 mg) on Days 1, 8 and 15, plus Lenalidomide (25 mg) on Days 1 to 21, and Dexamethasone (40 mg) on Days 1, 8, 15 and 22, of a 28-day cycle (Treatment Period II)
- id
- BG001
- title
- [KRd]; Carfilzomib + Lenalidomide + Dexamethasone Therapy
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.57
- value
- 71.8
- group Id
- BG001
- spread
- 9.40
- value
- 70.5
- group Id
- BG002
- spread
- 9.21
- value
- 70.7
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 21
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 24
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG002
- value
- 0
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Race and Ethnicity were not collected from any participant.
- title
- Race and Ethnicity Not Collected
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Japan
- description
- All participants were enrolled in Japan.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.70
- value
- 153.0
- group Id
- BG001
- spread
- 8.29
- value
- 158.5
- group Id
- BG002
- spread
- 8.58
- value
- 157.8
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height
- unit Of Measure
- Centimeters (cm)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.204
- value
- 52.85
- group Id
- BG001
- spread
- 10.380
- value
- 57.87
- group Id
- BG002
- spread
- 10.081
- value
- 57.17
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 43
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- Weight
- unit Of Measure
- Kilograms (kg)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 2.619
- value
- 22.60
- group Id
- BG001
- spread
- 2.512
- value
- 22.91
- group Id
- BG002
- spread
- 2.497
- value
- 22.86
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 43
- units
- Participants
- description
- Body Mass Index = weight (kg)/\[height (m)\^2\]
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- BMI
- unit Of Measure
- Kilogram (kg)/meter (m)^2]
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.1395
- value
- 1.487
- group Id
- BG001
- spread
- 0.1760
- value
- 1.583
- group Id
- BG002
- spread
- 0.1732
- value
- 1.569
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 43
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- Body Surface Area
- unit Of Measure
- m^2
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 19
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage I
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 17
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage II
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 9
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage III
- description
- International Staging System is a staging system for cancer progression. Stages are classified by Stage I to Stage III. Stage I: Serum beta2-microglobulin \<3.5 mg/L and albumin ≥3.5 g/dL; Stage II: Neither Stage I or III, meaning that either: beta2-microglobulin level ≥3.5 and \<5.5 mg/L (with any albumin level), OR albumin \<3.5 g/dL with beta2-microglobulin \<3.5 mg/L; Stage III: Serum beta2-microglobulin ≥5.5 mg/L. Normal serum beta2-microglobulin: \<3.0 mg/L; normal albumin: 3.5-5.0 g/dL.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- International Staging System (at Initial Diagnosis)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 24
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage I
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 13
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage II
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 5
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Stage III
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- International Staging System (at First Treatment [Period I])
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 33
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Scale = 0
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 10
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Scale = 1
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Scale = 2
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Scale = 3
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 45
- units
- Participants
- title
- Scale = 4
- description
- ECOG P.S.) assess participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory ( greater than \[\>\] 50 percent \[%\] of waking hours), capable of all self-care, unable to carry out any work activities; 3=capable of only limited self-care, confined to bed/chair \>50% of waking hours; 4=completely disabled, cannot carry on any self-care, totally confined to bed/chair; 5=dead.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group performance status (ECOG P.S.)
- unit Of Measure
- Participants
- population Description
- Full Analysis Set (FAS): all participants who were enrolled in Treatment Period I and who receive at least one dose of any therapy during the Treatment Period.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle